Platform Therapeutics, Inc.
PrivateLast Round
Seed Round
Aug 27, 2026
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Platform Therapeutics, Inc. is a clinical-stage life-science company that develops therapies to mitigate the toxic effects of chemotherapy and alleviate muscle cramps during dialysis.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Platform Therapeutics, Inc. Comparables
Compare Platform Therapeutics, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ting Therapeutics | 77% | |
| Acousia Therapeutics GmbH | 76% | |
| Regeneron Pharmaceuticals | 74% | |
Platform Therapeutics, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | Aug 27, 2026 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 27, 2026
Raised $1.75M in a Seed Round.
Platform Therapeutics, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Platform Therapeutics, Inc.'s valuation, stock price, and market status.